Production (Stage)
Foghorn Therapeutics Inc.
FHTX
$4.32
-$0.22-4.85%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.83M | -19.50M | -19.12M | -22.98M | -25.02M |
| Total Depreciation and Amortization | 827.00K | 761.00K | 733.00K | 791.00K | 835.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.32M | 2.34M | 2.62M | 6.31M | 4.09M |
| Change in Net Operating Assets | -9.28M | -8.12M | -5.23M | -9.66M | -9.25M |
| Cash from Operations | -23.97M | -24.52M | -21.01M | -25.54M | -29.35M |
| Capital Expenditure | -28.00K | -479.00K | -309.00K | -17.00K | -101.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 29.43M | 22.77M | -61.01M | -17.96M | 27.20M |
| Cash from Investing | 29.40M | 22.29M | -61.32M | -17.98M | 27.10M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 139.00K | 4.00K | 1.44M | 103.40M | 1.17M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -390.00K | -195.00K | -- |
| Cash from Financing | 139.00K | 4.00K | 1.05M | 103.21M | 1.17M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.57M | -2.22M | -81.27M | 59.69M | -1.08M |